Immunology has recently witnessed several new developments in understanding the biology of innate lymphocytes. In particular, the discovery of innate lymphoid cells (ILCs) has opened entirely new avenues for research. The exciting new developments in this rapidly expanding field were the focus of the 2 nd EMBO Conference on Innate Lymphoid Cells, which took place from November 30 to December 2, 2016 in Berlin, Germany. Here, we summarize the key new developments reported at the conference.
Our concept of hematopoietic lineages has recently received an important revision and extension by the discovery of a previously unrecognized diversity in innate lymphocyte subsets. These newly identified subsets of tissue-resident non-B and non-T lymphocytes are now collectively referred to as innate lymphoid cells (ILCs) (Figure 1 ) was a good opportunity to take stock of new developments in this dynamic field of research. In the two years since the last conference, the field has really broken novel ground and now also covers areas of metabolism, neuro-immune crosstalk, and hostmicrobe interaction, and some of these new developments are powered by the integration of cutting-edge sequencing technology. We highlight here the major new advances reported at this meeting.
ILC3 subsets might regulate an important component for the generation of the Th17 effector program, as noted by Dan Littman (Skirball Institute of Biomolecular Medicine, New York University) in the keynote lecture that opened the conference. The transcription factor RORgt (retinoic-acid-receptor-like orphan receptor gt) is a crucial factor required for the development of all ILC3 subsets, including LTi cells, as well as for the development of Th17 cells. He highlighted differences and analogies between the two lineages in relation to microbiota, specifically segmented filamentous bacteria (SFB). SFB-controlled cytokine production by Th17 cells requires serum amyloid A (SAA)1 and 2. Interestingly, SAA 1 and 2 expression is in part regulated by IL-22 produced by ILC3.
New Insights into ILC Development and Diversity:
The Power of ONE In the last years, our understanding of ILC development and diversity has been advanced by the description of ILC progenitors in mice and humans: the common helper-like ILC progenitor (CHILP) and a more restricted progenitor dubbed ILCp (i.e., CHILP2 in Figure 2 ). The transcriptional networks controlling early commitment to the ILC lineage are the focus of interest of many groups in the ILC field. ILCp, a precursor to all helper-like ILCs except LTi cells, expresses the transcription factor PLZF, and Gabrielle Belz (The Walter and Eliza Hall Institute, Melbourne) and Pentao Liu (Wellcome Trust Sanger Institute, Cambridge) have now found that the PLZF + subpopulation of CHILP can be conveniently identified by its expression of PD-1 (Seillet et al., 2016) . Albert Bendelac (University of Chicago) discussed the cell-intrinsic effect of PLZF deficiency on mature ILC2s, which show reduced effector functions, although PLZF expression is extinguished past the ILCp stage. Thus, PLZF expression at the ILCp stage has an effect on the functional properties of mature ILC2s, which have ceased to express PLZF. This may be related to the previously described role of PLZF in bestowing upon lymphocytes an innate gene expression program, possibly by modulating heritable epigenetic signatures.
Various groups have analyzed the temporal transcriptional control of gene expression across various lymphoid-restricted and ILC-restricted progenitors. Using single-cell transcriptional analysis of ILC progenitors, Gabrielle Belz found that transient NFIL3 expression upstream of the EILP was required for ILC commitment, which was followed by the induction of TCF-1 and then ID2, both of which were required to extinguish stem cell as well as T and B cell gene expression signatures (Seillet et al., 2016) . Hergen Spits (Academic Medical Center at the University of Amsterdam) investigated the role of ID2 in diverting early thymocytes toward the ILC lineage: overexpression of ID2 in human thymic progenitors enables their differentiation toward ILCs, and CD5 does not represent a T-cell-specific marker but can be expressed by immature ILCs. From these and other data, it is now well established that ID2 is a central hub in controlling helper-like ILC identity. Although NK cells are diminished as a population in mice genetically lacking ID2, it has been an open and controversial question as to whether ID2 is also required for commitment to the NK cell lineage. According to Barbara Kee (University of Chicago), development of thymic (t) NK cells was T-bet independent but NFIL3 dependent. However, neither ID2 nor ETS1 were essential for tNK cell development, although both proteins impacted the tNK cell phenotype. Collectively, these data provide important insights into the temporal and spatial control of the transcriptional machinery directing early ILC commitment, and they define important differences between the transcriptional requirements of the two main ILC branches, helper-like and cytotoxic ILCs (Figure 2 ).
Another unresolved question is whether ILCs can be replenished from circulating progenitors, whether they renew from tissue-resident precursors, or whether they might even self-renew in tissues as lineage-specified cells. Immune cell functional diversity such as that for ILCs is critical for the generation of different regulator and effector responses required for safeguarding the host against a broad range of threats but also for preventing the host from attacking its own healthy cells and tissues. The crosstalk and redundancies within these circuits and substantial cellular plasticity and heterogeneity pose a major challenge that can essentially only be 
ILCs, Circadian Rhythm, and Metabolism
An exciting new avenue of research stemmed from the discovery that ILCs are linked to physiological processes such as circadian rhythm and metabolism. Recent studies have unveiled a bidirectional communication between the biological clock and the mammalian gut microbiota and have shown that this communication is essential for host metabolic homeostasis. However, the mechanisms underlying these microbiota-clock interactions have remained a mystery. Lora Hooper (University of Texas Southwestern Medical Center) reported that ILCs play an important role in microbiota interactions with the intestinal circadian clock: intestinal ILCs relay microbiota signals to the epithelial circadian clock to regulate key metabolic pathways that control fat storage and body composition. These data suggest that ILCs represent an essential link between the microbiota, the circadian clock, and host metabolism.
How do ILCs regulate fat metabolism? Ajay Chawla (University of California San Francisco), using brown adipose tissue as a model system, discovered that licensing of postnatal functions in placental organs is signal dependent and independent of tissue differentiation programs. For example, the transition from the in utero maternal environment to postnatal life requires the activation of thermogenesis in placental mammals so they can maintain their core temperature, which is mediated by induction of uncoupling protein 1 (UCP1) in brown and beige adipocytes. He discovered that that the ''alarmin'' IL-33, which activates type 2 immune responses, licenses brown and beige adipocytes for uncoupled respiration. In the absence of IL-33, beige and brown adipocytes developed normally but had reduced levels of UCP1 protein, and uncoupled respiration and thermoregulation were impaired. Together, these data suggest that IL-33 and the IL-33 receptor function as a developmental switch to license thermogenesis during the perinatal period. Joe Sun (Memorial Sloan Kettering Cancer Centre, New York) identified a subset of long-term adipose-resident ILC1s that are dependent on the transcription factors NFIL3 and T-bet but phenotypically and functionally distinct from circulating mature NK cells. Dietinduced obesity drove early proinflammatory cytokine production in adipose tissue depots, leading to selective proliferation and accumulation of adipose-resident ILC1s. ILC1-derived IFN-g was both necessary and sufficient to drive proinflammatory macrophage polarization to promote obesity-associated insulin resistance. Therefore, these findings suggest that adiposeresident ILC1s contribute to metabolic disease in response to dysregulated local inflammation (O'Sullivan et al., 2016) .
Finally, Yasmine Belkaid (NIAID Bethesda) and Christoph Wilhelm (University of Bonn) investigated the impact of malnutrition, specifically of vitamin A deprivation, on ILCs. They found diminished representation and function of ILC3s, whereas ILC2s were more numerous and produced higher amounts of type 2 cytokines. As a consequence, mice deprived of vitamin A were more susceptible to bacterial infections normally contained by ILC3s but showed higher resistance to worm infections. Metabolic profiling of ILC2s showed that they depend on fatty acid oxidation and that they sustain and amplify their function by increased fatty acid metabolism. Thus, malnutrition leads to adaptive processes at barrier surfaces and skews the balance between ILC subsets toward a type 2 profile to favor immunity against worm infection. The lessons to be learned here are that ILCs and other components of the innate immune system are important and previously unappreciated elements of homeostatic circuits that evolved to adapt multicellular organisms to changes in their environment (e.g., circadian rhythm, postnatal thermogenesis, and nutrient deprivation). Much needs to be learned about how signals from the environment are sensed and how they are relayed to ILCs. Collectively, these data assign new roles to the evolutionarily older innate immune system in processes not conventionally assigned to the immune system.
Neuron-ILC Units
A newly emerging area of ILC research prominently featured at the meeting was that of neuro-immune interactions. Dan Littman demonstrated that ILC3s express vasoactive intestinal peptide receptor 2 (VIPR2), one of two receptors that bind VIP, a vasoactive peptide hormone produced by neurons. VIP-secreting neurons that interact with ILC3 were proposed to modulate cytokine expression. Henrique Veiga-Fernandes (Institute of Molecular Medicine Lisbon) showed that adult ILC3s are regulated by neuroglia signals. Notably, ILC3-autonomous ablation of the neuroregulator Ret leads to decreased production of IL-22, impaired epithelial reactivity, and increased susceptibility to inflammation and infection. ILC3s were found adjacent to neurotrophic-factorexpressing glial cells that exhibited stellate-shaped projections into ILC3 aggregates. Glial cells sensed microenvironmental cues in a MyD88-dependent manner to control neurotrophic factors. Thus, ILC3s can sense their environment as part of a neuroimmune cell unit orchestrated by neurotrophic factors (Ibiza et al., 2016) . Collectively, these data provide the first evidence that sensations of the outside world (e.g., light, pain, odor, etc.) that are integrated by the nervous system can be relayed to ILCs, which express receptors for neuron-derived transmitters and serve as effector cells in adapting the organism to the cues received. This will be an exciting area to watch, and a more rigorous analysis of the molecular nature of the crosstalk between ILCs and components of the nervous system is needed.
ILC-Stem-Cell Units
Research into ILCs has uncovered new paradigms, one of which has been a direct link between components of the innate immune system and their effector molecules (e.g., cytokines and growth factors) and epithelial stem cells. Such links shape organ function, homeostasis, and repair, processes that were previously widely believed to be epithelia intrinsic. Work by David Artis (Weill Cornell Medical College, New York) identified important roles for ILC2s in tissue protection in lung, gut, and adipose tissue. Such tissue protection was mediated by amphiregulin (AREG), an epidermal growth factor (EGF) family member produced at high levels by ILC2s. The AREG-EGF receptor axis was required for tissue repair and was linked to increased expression of mucins in epithelial cells. Richard Locksley (HHMI and University of California San Francisco) identified another signaling network for crosstalk between ILC2s and epithelial cells. He showed that intestinal epithelial Tuft cells produce high levels of IL-25 required to maintain and activate ILC2s. In the context of helminth infection, IL-25 stimulation of ILC2s resulted in increased IL-13 production by ILC2s. Remarkably, ILC2-derived IL-13 directly acted on intestinal stem cells or their progenitors to instruct fate decisions toward the secretory lineage, thereby promoting expulsion of worms (von Moltke et al., 2016) .
Mucosal barrier surfaces are continuously exposed to microbes and potentially hazardous or poisonous components derived from bacteria or contained in our diets and are, therefore, places of intense adaptive processes that converge to maintain barrier integrity and organ homeostasis. ILC3s produce substantial levels of IL-22, a peculiar cytokine whose receptor is specifically expressed on epithelial cells, including stem cells, allowing ILCs to directly control epithelial gene expression programs. Andreas Diefenbach (Charité and German Rheumatism Research Centre, Berlin) reported that IL-22 is required for the initiation of an effective DNA-damage response in intestinal epithelial stem cells in response to carcinogens and genotoxic nutrients. Consequently, mice lacking IL-22 or the IL-22 receptor developed cancer with a higher incidence and with accelerated kinetics. Alan Hanash (Memorial Sloan Kettering Cancer Centre, New York) linked ILC3-derived IL-22 to the protection of intestinal stem cells against alloreactive T cells in the context of graftversus-host disease (GvHD) (Lindemans et al., 2015) . Specifically, IL-22 enhanced proliferation of stem cells, increasing the efficiency of epithelial regeneration. It has been difficult to accurately assess the role of ILCs for such vital processes because experimental tools specifically and inducibly ablating ILC subsets were lacking. Gé rard Eberl (Institut Pasteur, Paris) reported the characterization of mice genetically modified to express the diphtheria toxin (DT) receptor (DTR) on specific ILC populations; such modification allows for the ablation of specific subsets after DT injections. In particular, in transgenic mice expressing the DTR under control of the locus coding for RORgt in ILC but not T cells, ILC3 were efficiently ablated within days. He reported a profound loss of intestinal-barrier function, along with significant effects on mouse physiology. Collectively, these and the above results further add to a growing body of evidence demonstrating previously unknown roles of ILCs for stem cell differentiation and maintenance of organ homeostasis, processes that were previously believed to be regulated in an epithelia-intrinsic manner. Genetic tools for the inducible and specific ablation of ILC subsets will allow researchers to more rigorously interrogate the contribution of specific ILC subsets to such processes.
Stroma-ILC Units ILC3 and, in particular, LTi cells have been recognized as closely interacting with stroma cell components to facilitate the formation of secondary lymphoid organs. Burkhard Ludewig (Kantonsspital St. Gallen) shared new results that suggest a substantial revision of the lymph-node organogenesis paradigm. This revision includes lymphatic endothelial cells as central players that determine the location and drive the initial steps of lymph-node formation. Moreover, Ludewig's group has found that production of the cytokine IL-15 by fibroblastic reticular cells (FRCs) is essential for the maintenance of group 1 ILCs in Peyer's patches and mesenteric lymph nodes. Conditional ablation of MyD88 exacerbated IL-15 production by FRC during intestinal viral infection, precipitating hyperactivation of group 1 ILCs and substantially altering intestinal homeostasis. Overall, the work shows that interaction between stromal cells and ILCs is important for immune processes during embryogenesis and for the maintenance of tissue homeostasis in the adult. Many of the cytokines required for ILC homeostasis are produced by specialized stroma-cell subsets. It will be an important trajectory of future research to identify and target diversity in stroma-cell components and investigate their impact on ILC maintenance, function, and plasticity. were found to be dysregulated in the context of pediatric inflammatory bowel disease (IBD). This provokes a challenge of how to selectively target pro-inflammatory T cell responses in patients with IBD without impairing the immunoregulatory functions of ILC3s. The group identified one potential approach when they determined that targeting of RORgt genetically or using small-molecule inhibitors could selectively limit pathologic T cell responses in the intestine while preserving the functions of ILC3s, thus limiting chronic intestinal inflammation (Withers et al., 2016) . Through comparative analysis of splenic and intestinal ILC3s, Daniela Finke (University Children's Hospital Basel) showed that the functional state of ILC3s and the result of the interaction between ILC3s and CD4 + T cells is not uniform but depends on tissue localization, type of activation, and disease status. This work has shed light on antigen-dependent reciprocal interactions between ILC3s and T cells. A disease-promoting role for ILC3s, ex-ILC3s, and ILC1s in chronic intestinal inflammation has previously been reported in mice and was later been confirmed in patients. Arthur Mortha (University of Toronto) and his colleagues Miriam Merad, Judy Cho, and Jean-Frederic Colombel (Icahn School of Medicine at Mount Sinai, New York) provided evidence for a feedback loop between ILC3s and intestinal myeloid cells in the mucosa of inflammatory bowel disease (IBD) patients. They report the identification of two subgroups of IBD patients, the first being genetically defective in receiving ILC3 signals and the second showing an altered crosstalk through aberrant B cell responses. Furthermore, Mortha reported that interactions between ILC3s and myeloid cells might be aberrant long before the onset of disease, opening ways to modulate ILC3 for a personalized management of IBD patients.
Immune Regulatory Networks Involving ILCs
Another layer of regulatory effects was revealed by work from Shigeo Koyasu (RIKEN Yokohama) and Jö rg Fritz (McGill University, Montreal), who documented a negative regulatory role of interferons and IL-27 for ILC2 function both in vitro and in vivo. They demonstrated that type I IFN (i.e., IFN-a/b), type II IFN (i.e., IFN-g), and IL-27 blocked proliferation of ILC2s in response to IL-2, IL-25, and IL-33 in a STAT1-dependent manner (Duerr et al., 2016; Moro et al., 2016) . Taken together, these data provide important insights into how ILCs regulate immunity and how signals of other immune cells regulate ILC function. Given the similarities in the effector programs of ILC and Th cells, regulatory pathways that selectively target inflammatory Th cells but leave ILCs untouched might pave the way for new therapeutic strategies.
Redundancy versus Necessity
The contributions of ILCs to immunity in natural conditions in humans have remained unclear. Eric Vivier (CIML Marseille) investigated the presence of ILCs in a cohort of patients with severe combined immunodeficiency (SCID). All ILC subsets were absent in SCID patients whose copy of the gene encoding the common g-chain cytokine receptor subunit or the gene encoding the tyrosine kinase JAK3 was mutated. T cell reconstitution was observed in patients with SCID after hematopoietic stem cell transplantation (HSCT), but the patients still had considerably fewer ILCs in the absence of myeloablation than did healthy control subjects. Remarkably, such reduced amounts of ILCs were not associated with any particular susceptibility to disease, according to follow-up reports extending from 7 to 39 years after HSCT. Thus, ILCs appear to be dispensable or only to be required in small numbers for protective immunity in humans, as long as T cells are present and B cell function is preserved, at least in the context of modern medicine and hygiene and in the ontogenetic window investigated. These findings open the possibility of using therapeutic ILC depletion as a safe intervention for inflammatory disorders and will certainly stimulate discussions concerning non-redundant roles of ILCs (Vé ly et al., 2016) .
Adaptive Traits and Immune Recognition by ILCs
ILCs express multiple activating innate immune receptors. It is poorly understood which aspect of helper-like ILC function is controlled by such activating immune receptors. In addition, the ligands for some of these receptors (e.g., NKp44 and NKp46) have remained elusive for almost 20 years. Marco Colonna (Washington University, St. Louis) presented a novel approach based on an unbiased screen of a secretome protein library. This approach uses NKp44 reporter cells so that engagement of a NKp44 ligand would activate GFP expression. From the uppermost 30 hits from the screen, the top NKp44 ligand (NKp44L) was validated, which induced IFN-g and TNF secretion by natural killer (NK) cells and ILCs. NKp44L was overexpressed by numerous different human cancers with aggressive features, and the number of NKp44L + B16.F10 lung metastases was reduced in NKp44 transgenic mice as compared to non-transgenic littermates.
Another important topic was whether triggering of activating immunoreceptors contributes to the formation of a pool of ''antigen-experienced'' ILCs. Chiara Romagnani (Charité and German Rheumatism Research Centre, Berlin) has elucidated the antigen-recognition properties of NKG2C + adaptive NK cells, which undergo clonal-like expansion after human cytomegalovirus (CMV) infection. In her study, Romagnani demonstrated that NKG2C + NK cells recognize with different functional avidity polymorphic peptides derived from distinct CMV strains, further showing that interaction of NKG2C with high-affinity peptides contribute to the accumulation of NKG2C + adaptive NK cells. Collectively, the data from the Romagnani and Colonna labs re-iterate the importance of immunoreceptor-based signaling for the control of ILC activation and the formation of memory-like qualities of ILCs. Although all helper-like ILC subsets express activating immunoreceptors, it is still widely believed that their activity is mainly controlled by soluble factors. It will be an important goal to understand whether ILCs are regulated by immunoreceptorbased signals (which would require cell-cell-contact) or soluble, longer-range signals.
Conclusions and Perspectives
Over the past few years, the ILC field has rapidly spread into various areas of physiology, including metabolism, circadian rhythm, and maintenance of homeostatic equilibrium at mucosal sites. These advances were well captured by the dense program at the 2 nd EMBO Conference on Innate Lymphoid Cells and by the lively discussions after the talks and at the posters (Figure 1 ). Such research has been made possible by various discoveries, including those demonstrating that ILCs produce factors that can control differentiation and function of non-immune cells such as epithelial stem cells, adipocytes, and stroma cell components; such discoveries link the immune system to processes not conventionally assigned to the immune system. An interesting new avenue in ILC research was opened by various laboratories showing that ILC function is fine-tuned when the nervous system processes sensations induced by the outside world (in response to light, pain, odor, etc.) and sends signals to the immune system. In addition to this, questions of transcriptional control of ILC fate and questions concerning the signals directing ILC differentiation into the three known ILC modules will be important areas to investigate. In light of recent data showing that adult humans with very low numbers of ILCs show no increased susceptibility to infection, the field will need to assess unique and redundant functions of ILCs across ontogeny. Stay tuned for the next visit to the brave new world of ILCs in 2018 in Japan (Organizer: Shigeo Koyasu).
